• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CHRISTOPH MIETHKE GMBH & CO. KG PROGAV 2.0 SYS PED.W/SA15 A.PRECHAMBER; HYDROCEPHALUS MANAGEMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CHRISTOPH MIETHKE GMBH & CO. KG PROGAV 2.0 SYS PED.W/SA15 A.PRECHAMBER; HYDROCEPHALUS MANAGEMENT Back to Search Results
Model Number FX440T
Device Problems Mechanical Problem (1384); Increase in Pressure (1491)
Patient Problem Hydrocephalus (3272)
Event Date 07/01/2020
Event Type  Injury  
Manufacturer Narrative
Additional information / investigation results will be provided in a supplemental report, if available.
 
Event Description
It was reported that there was a problem with a progav 2.0.The patient was implanted with the shunt, the product failed to regulate pressure and the patient developed symptoms of high intracranial pressure.After two months the doctor removed the shunt and reimplanted a new product.Patient information: age: (b)(6) years.Weight: (b)(6).Hight: 178 cm.Gender: unknown.Implantation: (b)(6) 2020.Explantation: (b)(6) 2020.
 
Manufacturer Narrative
New information are provided with returned product.The serial number indicated a different delivery lot as the previous one.Additional data about the patient were transmitted.These have been updated in this follow up report.D4 model: fx440t.D10 device returned by manufacturer 08/04/2020.G5 pma/510(k) number: k161853.In addition, the product has now been finally investigated.Investigation results: visual inspection: no deviations are detected.Permeability test: the test showed that the progav 2.0 is permeable.Computer controlled test: the test has shown the opening pressure of the progav 2.0, at a reference flow rate of 20 ml/hr in a horizontal position, to be 1.39 cmh2o.This is not within the specified tolerance of 7 cmh2o ± 3 cmh2o.An applied pressure of 1.39 cmh2o, with the device in the horizontal position is expected to have a resultant opening pressure of 7 cmh2o ± 3 cmh2o.Additional testing did not significantly change the results.According to our results, we can observe a presence of an over- drainage.Adjustability test: the progav 2.0 was found to be found to be non-adjustable within the specified range.Braking force and brake function test: the braking force test indicates that the brake function of the progav 2.0 is present due to the non-adjustability of the valve, an investigation of the braking force was not possible.Internal inspection of product: after dismantling of the valve, clearly deposits were found in progav 2.0.Results: based on our investigation, we are not able to substantiate the claim of "under-drainage" but we confirm the presence of "non-adjustability" and "over- drainage".We are assuming that the deposits detected within the valve have caused the functional impairment.Deposits caused by natural substances in the cerebrospinal fluid, such as protein, blood or tissue particles, are among the known and unavoidable risks and side effects of hydrocephalus therapy.We can exclude a defect at the time of release.The valve met all specifications of the final inspection when released from christoph miethke gmbh & co.Kg.From our point of view, no further regulatory actions are required.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROGAV 2.0 SYS PED.W/SA15 A.PRECHAMBER
Type of Device
HYDROCEPHALUS MANAGEMENT
Manufacturer (Section D)
CHRISTOPH MIETHKE GMBH & CO. KG
2 ulanenweg
potsdam, 14469
GM  14469
MDR Report Key10373032
MDR Text Key202006717
Report Number3004721439-2020-00149
Device Sequence Number1
Product Code JXG
Combination Product (y/n)N
PMA/PMN Number
K161853
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,user f
Type of Report Initial,Followup
Report Date 08/19/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/06/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date05/08/2023
Device Model NumberFX440T
Device Catalogue NumberFX440T
Device Lot Number20037830
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer08/04/2020
Date Manufacturer Received08/04/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age28 YR
Patient Weight70
-
-